Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.
Detected in mice treated with 0.25% MXF
Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis.
detected by MTBDRsl assay
Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase.
Mutations in the quinolone resistance-determining regions (QRDR) of GyrA and GyrB.
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Previously reported
Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.
Mutations in gyrA were associated with resistance to fluoroquinolones.
Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis.
Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition.
Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance.
Mutations in gyrA were associated with ofloxacin resistance.
Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.
mutations detected in 7 strains
Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay.
Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.
associated with fluoroquinolone resistance
Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.
Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.
Molecular characteristics of ofloxacin mono-resistant Mycobacterium tuberculosis isolates from new and previously treated tuberculosis patients.
Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
Mutations in gyrA and gyrB are associated with fluoroquinolone resistance in Mycobacterium tuberculosis.
Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.
Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China.
Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the Philippines.
Common mutations underlying fluoroquinolone resistance.
Whole-genome sequencing reveals transmission pattern and drug resistance of Mycobacterium tuberculosis intra- or inter-hosts.
Clinical characteristics and genomic epidemiological survey of tuberculosis in Wuzhou, China, 2022.
Identification and quantification of gyrA variants in fluoroquinolone-resistant Mycobacterium tuberculosis in a MeltArray reaction.
All mutations are in the quinolone resistance-determining region (QRDR) of gyrA.
Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009.
The S95T mutation in gyrA was a natural polymorphism and not considered a resistance mechanism.
Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.
Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays.
Mutations in gyrA lead to false-positive fluoroquinolone resistance results
Correlation of gyr Mutations with the Minimum Inhibitory Concentrations of Fluoroquinolones among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh.
Mutations in the gyrA gene are associated with fluoroquinolone resistance in MDR-TB isolates.
Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
Evaluation of the Xpert MTB/XDR test for detection of isoniazid, fluoroquinolones, and second-line injectable drugs resistance to Mycobacterium tuberculosis-Anhui Province, China.
Fluoroquinolone and Second-Line Injectable Resistance Among Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates: A Molecular Study from a High-Burden Setting.
mutations in gyrA are associated with fluoroquinolone resistance
A novel one-tube nested fluorescence melting curve analysis for rapid detection of drug-resistant Mycobacterium tuberculosis.
All mutations were confirmed by DNA sequencing.
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
associated with ofloxacin resistance
Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
Mutations in gyrA are associated with fluoroquinolone resistance in Mycobacterium tuberculosis.
Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
Mutations in gyrA are associated with fluoroquinolone resistance.
Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
Mutations in the gyrA gene associated with fluoroquinolone resistance
Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
Mutations in gyrA are associated with fluoroquinolone resistance in Mycobacterium tuberculosis.
Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside Resistance.
Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.
Mutations in gyrA QRDR correlate with increased MICs for fluoroquinolones.
Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectables Drugs: a Multicenter Study.
Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.
Mutations in gyrA were correlated with levofloxacin resistance.
Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis.
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
The Genetic Background Modulates the Evolution of Fluoroquinolone-Resistance in Mycobacterium tuberculosis.
Most prevalent in high-frequency OFX-R strains.
Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant Mycobacterium tuberculosis clinical isolates in southern China.
Novel mutations detected in gyrA and gyrB genes.
Molecular characterization of pre-extensive drug resistant Mycobacterium tuberculosis in Northeast Brazil.
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.
Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains.
Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis.
High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
mutations in gyrA and gyrB are responsible for fluoroquinolone resistance in M. tuberculosis
Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients.
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China.
In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis.
Mutations in gyrA associated with fluoroquinolone resistance
FLASH-TB: an Application of Next-Generation CRISPR to Detect Drug Resistant Tuberculosis from Direct Sputum.
Evolution and epidemic success of Mycobacterium tuberculosis in eastern China: evidence from a prospective study.
Mutations in gyrA are associated with fluoroquinolone resistance.
Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment.
Rapid detection of fluoroquinolone resistance in Mycobacterium tuberculosis using a novel multienzyme isothermal rapid assay.
Mutations in codons 90 and 94 of gyrA are associated with fluoroquinolone resistance.
A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
Mutations in gyrA codons 90, 91, and 94 are commonly associated with fluoroquinolone resistance.
Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis.
Mutations in gyrA gene confer resistance to fluoroquinolones.
Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa.
Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.
Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.
Heterozygous mutations were observed in 4/27 (14.8%) mutations.
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Mutations in gyrA contribute to quinolone resistance in Mycobacterium tuberculosis.
Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge.
Mutations in gyrA were analyzed for their association with resistance to fluoroquinolones.
Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones.
Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
Mutations promoted from gene entry 'gyrA' (model emitted mutations_found inside genes).
Resistance-Conferring Mutations on Whole-Genome Sequencing of Fluoroquinolone-resistant and -Susceptible Mycobacterium tuberculosis Isolates: A Proposed Threshold for Identifying Resistance.
Mutations in gyrA and gyrB are the most frequent mechanism of fluoroquinolone resistance.
Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment.
Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.
Mutations in gyrA are associated with high-level resistance to fluoroquinolones.
Fitness Cost and Compensatory Evolution in Levofloxacin-Resistant Mycobacterium aurum.
mutations in quinolone-resistance-determining region of gyrA gene
c-di-AMP signaling plays important role in determining antibiotic tolerance phenotypes of Mycobacterium smegmatis.
Mutation in the quinolone resistance-determining region (QRDR) of gyrA leads to ciprofloxacin resistance.
A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.
mutations in gyrA are associated with fluoroquinolone resistance
Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones; CARD accession: CARD:3003295
Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis.
Mutations in gyrA lead to evybactin resistance
Whole-genome sequencing for surveillance of fluoroquinolone resistance in rifampicin-susceptible tuberculosis in a rural district of Shanghai: A 10-year retrospective study.
Mutations in gyrA were associated with fluoroquinolone resistance in Mycobacterium tuberculosis.
Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru.
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones; CARD accession: CARD:3003295
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.
Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones; CARD accession: CARD:3003295
Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones; CARD accession: CARD:3003295
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Detection of streptomycin and quinolone resistance in Mycobacterium tuberculosis by a low-density DNA array.
Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.
Tuberculosis drug resistance mutation database.
Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction.
Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance.
Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments.
Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.
Globally diverse Mycobacterium tuberculosis resistance acquisition: a retrospective geographical and temporal analysis of whole genome sequences.
Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study.
Potential of nanopore sequencing for tuberculosis diagnosis and drug resistance detection.
Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study.
Mutations in gyrA were identified in 7 (24.1%) of patients.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research